Stocks in play: Cognetivity Neurosciences Ltd
Announced that it has signed a distribution agreement with Dubai-based medical technology company Emitac Healthcare Solutions. Under the terms, Emitac has become an official distributor of CognICA™, Cognetivity's medical device product, in the Middle East region. Emitac is a leading healthcare innovator and solutions provider in the Middle East, boasting public- and private-sector organisations among its customers and clients, from Dubai Healthcare City and the United Arab Emirates Ministry of Health & Prevention to Cleveland Clinic, Samsung Ultrasound Systems and Philips Healthcare. Cognetivity Neurosciences Ltd shares C.CGN are trading down 0.01 cent at $0.49.
Read:
Optimism on the Rise Thanks to New Developments in Oncology in the Fight Against Cancer
Double-Digit Growth in Global Cancer Immunotherapy Market to Drive Advancements Ahead of 2030
Wave of Massive ESG Investments Triggering Major Developments in Mining of Critical Minerals
Investment in New Plant-Based Alternative Meat Products Ramps Up Into 2022
New Treatments Needed as Breast Cancer Was Leading Killer of Female Cancer Patients in 2019